Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
A second case of acute myeloid leukemia (AML) with a t(2;4)(p23;q25) as the sole anomaly is reported. Our case had a de novo AML (M2); the case previously described had AML (M2) post-MDS. It is suggested that t(2;4)(p23;q25) is a new, recurrent, but rare anomaly in AML.
Shi
G
G
Department of Oncology-Hematology, Medical University Clinic, Hamburg, Germany.
Weh
H J
HJ
Hossfeld
D K
DK
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002871:Chromosome Banding; D002889:Chromosomes, Human, Pair 2; D002894:Chromosomes, Human, Pair 4; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000235:genetics*; D014178:Translocation, Genetic
D003561:Cytarabine; D005047:Etoposide; D003630:Daunorubicin